Christina L Runge1, Amit Indap2, Yifan Zhou3, Jack W Kent4, Ericka King1, Christy B Erbe1, Regina Cole5, Jack Littrell5, Kate Merath5, Roland James5, Franz Rüschendorf6, Joseph E Kerschner1, Gabor Marth7, Norbert Hübner6, Harald H H Göring4, David R Friedland1, Wai-Meng Kwok8, Michael Olivier9. 1. Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee. 2. Department of Biology, Boston College, Chestnut Hill, Massachusetts. 3. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee. 4. Department of Genetics, Texas Biomedical Research Institute, San Antonio. 5. Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee. 6. Max Delbrück Center for Molecular Medicine, Berlin-Buch, Germany. 7. Department of Human Genetics, University of Utah School of Medicine, Salt Lake City. 8. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee8Department of Anesthesiology, Medical College of Wisconsin, Milwaukee. 9. Department of Genetics, Texas Biomedical Research Institute, San Antonio5Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee.
Abstract
IMPORTANCE: Sensorineural hearing loss (SNHL) is commonly caused by conditions that affect cochlear structures or the auditory nerve, and the genes identified as causing SNHL to date only explain a fraction of the overall genetic risk for this debilitating disorder. It is likely that other genes and mutations also cause SNHL. OBJECTIVE: To identify a candidate gene that causes bilateral, symmetric, progressive SNHL in a large multigeneration family of Northern European descent. DESIGN, SETTING, AND PARTICIPANTS: In this prospective genotype and phenotype study performed from January 1, 2006, through April 1, 2016, a 6-generation family of Northern European descent with 19 individuals having reported early-onset hearing loss suggestive of an autosomal dominant inheritance were studied at a tertiary academic medical center. In addition, 179 unrelated adult individuals with SNHL and 186 adult individuals reporting nondeafness were examined. MAIN OUTCOMES AND MEASURES: Sensorineural hearing loss. RESULTS: Nine family members (5 women [55.6%]) provided clinical audiometric and medical records that documented hearing loss. The hearing loss is characterized as bilateral, symmetric, progressive SNHL that reached severe to profound loss in childhood. Audiometric configurations demonstrated a characteristic dip at 1000 to 2000 Hz. All affected family members wear hearing aids or have undergone cochlear implantation. Exome sequencing and linkage and association analyses identified a fully penetrant sequence variant (rs35725509) on chromosome 12q21 (logarithm of odds, 3.3) in the TMTC2 gene region that segregates with SNHL in this family. This gene explains the SNHL occurrence in this family. The variant is also associated with SNHL in a cohort of 363 unrelated individuals (179 patients with confirmed SNHL and 184 controls, P = 7 × 10-4). CONCLUSIONS AND RELEVANCE: A previously uncharacterized gene, TMTC2, has been identified as a candidate for causing progressive SNHL in humans. This finding identifies a novel locus that causes autosomal dominant SNHL and therefore a more detailed understanding of the genetic basis of SNHL. Because TMTC2 has not been previously reported to regulate auditory function, the discovery reveals a potentially new, uncharacterized mechanism of hearing loss.
IMPORTANCE: Sensorineural hearing loss (SNHL) is commonly caused by conditions that affect cochlear structures or the auditory nerve, and the genes identified as causing SNHL to date only explain a fraction of the overall genetic risk for this debilitating disorder. It is likely that other genes and mutations also cause SNHL. OBJECTIVE: To identify a candidate gene that causes bilateral, symmetric, progressive SNHL in a large multigeneration family of Northern European descent. DESIGN, SETTING, AND PARTICIPANTS: In this prospective genotype and phenotype study performed from January 1, 2006, through April 1, 2016, a 6-generation family of Northern European descent with 19 individuals having reported early-onset hearing loss suggestive of an autosomal dominant inheritance were studied at a tertiary academic medical center. In addition, 179 unrelated adult individuals with SNHL and 186 adult individuals reporting nondeafness were examined. MAIN OUTCOMES AND MEASURES: Sensorineural hearing loss. RESULTS: Nine family members (5 women [55.6%]) provided clinical audiometric and medical records that documented hearing loss. The hearing loss is characterized as bilateral, symmetric, progressive SNHL that reached severe to profound loss in childhood. Audiometric configurations demonstrated a characteristic dip at 1000 to 2000 Hz. All affected family members wear hearing aids or have undergone cochlear implantation. Exome sequencing and linkage and association analyses identified a fully penetrant sequence variant (rs35725509) on chromosome 12q21 (logarithm of odds, 3.3) in the TMTC2 gene region that segregates with SNHL in this family. This gene explains the SNHL occurrence in this family. The variant is also associated with SNHL in a cohort of 363 unrelated individuals (179 patients with confirmed SNHL and 184 controls, P = 7 × 10-4). CONCLUSIONS AND RELEVANCE: A previously uncharacterized gene, TMTC2, has been identified as a candidate for causing progressive SNHL in humans. This finding identifies a novel locus that causes autosomal dominant SNHL and therefore a more detailed understanding of the genetic basis of SNHL. Because TMTC2 has not been previously reported to regulate auditory function, the discovery reveals a potentially new, uncharacterized mechanism of hearing loss.
Authors: John Blangero; Harald H H Goring; Jack W Kent; Jeff T Williams; Charles P Peterson; Laura Almasy; Thomas D Dyer Journal: Hum Biol Date: 2005-10 Impact factor: 0.553
Authors: Vedat Topsakal; Ronald J E Pennings; Heleen te Brinke; Ben Hamel; Patrick L M Huygen; Hannie Kremer; Cor W R J Cremers Journal: Otol Neurotol Date: 2005-01 Impact factor: 2.311
Authors: Raye L Alford; Kathleen S Arnos; Michelle Fox; Jerry W Lin; Christina G Palmer; Arti Pandya; Heidi L Rehm; Nathaniel H Robin; Daryl A Scott; Christine Yoshinaga-Itano Journal: Genet Med Date: 2014-03-20 Impact factor: 8.822
Authors: Ida Signe Bohse Larsen; Yoshiki Narimatsu; Hiren Jitendra Joshi; Lina Siukstaite; Oliver J Harrison; Julia Brasch; Kerry M Goodman; Lars Hansen; Lawrence Shapiro; Barry Honig; Sergey Y Vakhrushev; Henrik Clausen; Adnan Halim Journal: Proc Natl Acad Sci U S A Date: 2017-10-02 Impact factor: 11.205
Authors: Jiang Li; Omar Akil; Stephanie L Rouse; Conor W McLaughlin; Ian R Matthews; Lawrence R Lustig; Dylan K Chan; Elliott H Sherr Journal: J Clin Invest Date: 2018-10-15 Impact factor: 14.808
Authors: Hector Guillen-Ahlers; Christy B Erbe; Frédéric D Chevalier; Maria J Montoya; Kip D Zimmerman; Carl D Langefeld; Michael Olivier; Christina L Runge Journal: Mol Genet Genomic Med Date: 2018-04-19 Impact factor: 2.183
Authors: Jill B Graham; Johan C Sunryd; Ketan Mathavan; Emma Weir; Ida Signe Bohse Larsen; Adnan Halim; Henrik Clausen; Hélène Cousin; Dominque Alfandari; Daniel N Hebert Journal: Mol Biol Cell Date: 2019-12-18 Impact factor: 4.138
Authors: Birgit Eisenhaber; Swati Sinha; Chaitanya K Jadalanki; Vladimir A Shitov; Qiao Wen Tan; Fernanda L Sirota; Frank Eisenhaber Journal: Biol Direct Date: 2021-01-12 Impact factor: 4.540